Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 2181-2200 of 3,170 trials

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

NCT03357471

The purpose of the study is to evaluate the ability of subjects who are already prescribed Certolizumab Pergol therapy and have been self injecting with prefilled syringes for at least the previous three months, to safely and effectively self-inject Certolizumab Pegol (CZP) using the e-Device and to evaluate the post-use structural integrity of used devices and cassettes via visual examination.

Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more

UCB Biopharma S.P.R.L.70 participantsStarted Nov 2017

Mesa, Arizona, United States • Mesa, Arizona, United States • Phoenix, Arizona, United States +19 more locations

TERMINATEDPhase 3< 1 mile

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

NCT02247531

This study is a Phase III, double-masked, multicenter, randomized, sham injection-controlled study evaluating the efficacy and safety of lampalizumab administered by intravitreal injections in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Geographic Atrophy

Hoffmann-La Roche975 participantsStarted Oct 2014

Phoenix, Arizona, United States • Tucson, Arizona, United States • Fullerton, California, United States +150 more locations

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Rheumatoid Arthritis Trials in Other Cities

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

A Study in Moderate to Severe Rheumatoid Arthritis Participants

Evaluating the Acute Glycemic Response to Different Strategies of Breaking Up Sedentary Time

Everolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Long-Term Safety and Tolerability of Mesalamine Pellets in Participants With Ulcerative Colitis in Remission

Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis

Soft Contacts Observation of Risk and Education (SCORE)

CONTINuous Infra-Inguinal Stenting Using the Bard® LifeStent® VascUlar Stent SysteMs ("CONTINUUM")

Study Evaluating Two Dose Levels of Targretin Capsules in Participants With Refractory Cutaneous T-Cell Lymphoma (CTCL)

Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

SPRINT - Randomized Trial of Tibial Fracture Fixation

TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

A Study of Factors That Affect Long-Term Kidney Transplant Function

Other Conditions in Phoenix